CVE-2024-49792: IBM ApplinX Cross-Site Scripting
IBM ApplinX 11.1 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Other sources
IBM ApplinX is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
— IBM
Affected Software
Event History
Frequently Asked Questions
What is the severity of CVE-2024-49792?
CVE-2024-49792 has a high severity rating due to its potential to allow authenticated users to execute arbitrary JavaScript code.
How do I fix CVE-2024-49792?
To fix CVE-2024-49792, apply the IBM ApplinX 11.1.0 Fix 2 patch available from IBM's support site.
Who is affected by CVE-2024-49792?
CVE-2024-49792 affects users of IBM ApplinX version 11.1.
What are the consequences of CVE-2024-49792?
Exploitation of CVE-2024-49792 can lead to the disclosure of credentials and compromise of session security.
Is user authentication required to exploit CVE-2024-49792?
Yes, exploitation of CVE-2024-49792 requires that the attacker be an authenticated user.